A shocking new study has illuminated the dire realities of illicit drug use within Queensland correctional facilities, revealing that over 80 inmates once shared a single needle for injecting drugs in a single day. The research, published in the prestigious International Journal of Drug Policy, draws on the harrowing accounts of more than 30 former prisoners, painting a grim picture of health risks and desperate measures taken behind bars.
One 42-year-old former inmate recounted a terrifying two-year period where he repeatedly shared the same needle, a practice that dramatically amplifies the danger of contracting severe bacterial and viral infections, including HIV and Hepatitis C.
Urgent Calls for Harm Reduction in Prisons
These findings have reignited a passionate debate among medical professionals, with numerous doctor groups advocating strongly for the implementation of needle and syringe exchange programs (NSEPs) within Australian prisons. Proponents argue that such programs are crucial for curbing the spread of infections, not only among the incarcerated population but also within the wider community upon their release.
However, a prominent union representing prison officers remains steadfastly opposed, raising significant concerns about the safety of its members.
Desperate Measures and DIY Equipment
In the absence of sterile injecting equipment, former prisoners revealed the lengths they went to in order to continue their drug use. Stories emerged of inmates sharpening blunt needle tips on concrete floors and employing nail files to “resurrect” used equipment. When syringes became unusable, prisoners resorted to crafting makeshift substitutes from everyday items, dramatically increasing their exposure to infection.
One former inmate shared a chilling experience: “One time I used a fit (syringe) made out of a bread bag, a pen and a sunscreen tube. They shot me up in the side of the foot, and it ended up getting infected, and I got acute hepatitis.”
The Perils of Untreated Infections
The study participants also expressed significant dissatisfaction with the healthcare provided for injection-related bacterial infections within prisons, citing a “lack of access to medical expertise” that often delayed crucial and appropriate treatment. The consequences, researchers noted, could be devastating.
“For some, this led to hospitalisation, permanent disability, and near loss of life,” the study authors stated. One individual reportedly fell into an induced coma after sharing a syringe and subsequently developing a spinal infection. His cellmate recounted, “They administered IV (intravenous) antibiotics to try and get rid of the infection. He nearly died.”
Bacterial infections originating from injecting drug use can have lifelong repercussions, potentially invading the spine, joints, and heart valves with severe and lasting damage. Another former inmate shared the tragic case of a fellow prisoner who developed an infection requiring hospitalisation and ultimately left him unable to walk, facing a future reliant on a wheelchair.
The Complexities of Drug Diversion
While illicit substances like heroin and methamphetamine are known to be smuggled into prisons, study co-author Tim Piatkowski from the University of Queensland (UQ) highlighted another insidious pathway for drug use. Inmates undergoing opioid treatment programs, receiving methadone or long-acting buprenorphine, sometimes divert these prescribed medications. These are then sold within an informal prisoner economy, facilitating further injecting drug use.
Dr. Piatkowski explained, “People were squeezing out that long-acting injection onto a Band-aid, cutting up that Band-aid and selling that Band-aid for people to inject.”
National Context and International Precedents
Australia’s prison population hovers around 47,000 adult inmates. Data from the Australian Institute of Health and Welfare indicates that a significant number of these individuals engage in injecting drug use while incarcerated, with approximately one in seven male inmates and one in 20 women admitting to such practices upon release.
Crucially, no Australian state or territory currently operates a prison-based needle and syringe exchange program. In contrast, these harm reduction initiatives are successfully implemented in correctional facilities in countries like Switzerland and Spain.
Advocacy for Harm Minimisation
Leading medical bodies, including the Australian Medical Association (AMA) and the Australasian Society for Infectious Diseases, are championing the introduction of NSEPs in Australian prisons. Infectious disease specialist Candice Holland, who treats prisoners and was not involved in the UQ study, stressed the urgency.
“We know that from recent data around the rates of new hepatitis C infections in Australia, a very high proportion of those are occurring in people who are exposed to unsafe injecting practices in the prison setting,” Dr. Holland stated. She believes Australia cannot achieve its goal of eliminating Hepatitis C as a public health threat by 2030 without implementing harm reduction strategies within correctional facilities.
Dr. Holland suggested a phased approach, proposing a pilot program in “one or two” low-security jails, drawing on successful international models, before considering a broader rollout. Addressing concerns that NSEPs might encourage drug use, she asserted, “We know that’s not the case.” She pointed to decades of experience with NSEPs in the Australian community, which have consistently led to increased engagement with healthcare professionals and, paradoxically, a decrease in injection rates.
A Matter of Human Rights
Julian Rait, vice-president of the Australian Medical Association (AMA), has labelled the absence of NSEPs in prisons a “human rights issue,” given their widespread availability in the broader community.
“It bothers the AMA that it doesn’t seem that prisoners can access the same level of care as others in the community expect,” Associate Professor Rait commented. He emphasised the dual benefit of such programs: improving the health of prisoners and, by extension, protecting the public from the transmission of blood-borne viruses upon release.
“If possible, we need to be able to reduce the risk of retransmission of these viruses within the prison system and try and get people onto treatment. But as a first priority of harm minimisation, I think a needle and syringe exchange program would be a simple approach to try and reduce the prevalence of these conditions within the prison system and therefore, better protect the community when they’re released.”
Opposition and Security Concerns
The Community and Public Sector Union (CPSU), representing prison officers in most Australian states and territories, remains firmly against the introduction of NSEPs in correctional settings. Federal secretary Stewart Little stated unequivocally, “We would never support that. From our point of view, we’ve seen no evidence put to us that by introducing needles you’re going to make it safer on the ground for officers, indeed for other inmates.”
Mr. Little raised concerns about the potential for needles to be weaponised by inmates and predicted significant industrial action if such programs were to be implemented.
Jurisdictional Responses
When approached by ABC News, state and territory governments across Australia were asked about their plans for introducing prison NSEPs. None indicated any intention to develop even a pilot program.
- Queensland Corrective Services stated it offers substance and addiction “desistance programs” and was “not aware of a needle exchange program in any Australian prison.”
- The Victorian Department of Justice and Community Safety maintains a “zero-tolerance approach to illegal drugs and sharp objects that present a security risk.”
- NSW Health expressed support for evidence-based harm reduction strategies, including blood-borne virus testing and treatment, peer education, and access to practical prevention supplies like disinfectants.
- SA Health reported that while no prisoner-based NSEP is in place, significant efforts are made to support the health of those in custody, noting a substantial decrease in Hepatitis C prevalence due to curative treatments.
- The West Australian Justice Department cited “reasons of safety and security” as the basis for not considering NSEPs at this time.
- ACT Corrective Services is monitoring international research but has “significant concerns remain[ing] regarding the safety of ACT Corrective Services’ staff,” and NSEPs are “not an activity that is under consideration.”
- NT Health acknowledged the evidence supporting NSEPs in reducing blood-borne virus transmission but stated they are not offered in prisons, though all inmates are routinely screened.
